215 related articles for article (PubMed ID: 29155144)
21. Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide.
Zhou Z; Martin E; Sharina I; Esposito I; Szabo C; Bucci M; Cirino G; Papapetropoulos A
Pharmacol Res; 2016 Sep; 111():556-562. PubMed ID: 27378567
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum.
Estancial CS; Rodrigues RL; De Nucci G; Antunes E; Mónica FZ
BJU Int; 2015 Oct; 116(4):657-64. PubMed ID: 25715977
[TBL] [Abstract][Full Text] [Related]
23. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
[TBL] [Abstract][Full Text] [Related]
24. Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats.
Jabs A; Oelze M; Mikhed Y; Stamm P; Kröller-Schön S; Welschof P; Jansen T; Hausding M; Kopp M; Steven S; Schulz E; Stasch JP; Münzel T; Daiber A
Vascul Pharmacol; 2015 Aug; 71():181-91. PubMed ID: 25869522
[TBL] [Abstract][Full Text] [Related]
25. Effects of hydrogen peroxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
Free Radic Res; 2015; 49(12):1479-87. PubMed ID: 26334090
[TBL] [Abstract][Full Text] [Related]
26. Thermal shift assay: Strengths and weaknesses of the method to investigate the ligand-induced thermostabilization of soluble guanylyl cyclase.
Elgert C; Rühle A; Sandner P; Behrends S
J Pharm Biomed Anal; 2020 Mar; 181():113065. PubMed ID: 32032919
[TBL] [Abstract][Full Text] [Related]
27. Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat.
Kollau A; Opelt M; Wölkart G; Gorren ACF; Russwurm M; Koesling D; Mayer B; Schrammel A
Mol Pharmacol; 2018 Feb; 93(2):73-78. PubMed ID: 29138269
[TBL] [Abstract][Full Text] [Related]
28. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
29. Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor.
Füllhase C; Hennenberg M; Sandner P; Strittmatter F; Niedworok C; Bauer RM; Gratzke C; Soler R; Stief C; Andersson KE
Neurourol Urodyn; 2015 Nov; 34(8):787-93. PubMed ID: 25230878
[TBL] [Abstract][Full Text] [Related]
30. Hemodynamic Effects of a Soluble Guanylate Cyclase Stimulator, Riociguat, and an Activator, Cinaciguat, During NO-Modulation in Healthy Pigs.
Næsheim T; How OJ; Myrmel T
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):75-87. PubMed ID: 32662299
[TBL] [Abstract][Full Text] [Related]
31. Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo Studies.
Ferreira WA; Chweih H; Lanaro C; Almeida CB; Brito PL; Gotardo EMF; Torres L; Miguel LI; Franco-Penteado CF; Leonardo FC; Garcia F; Saad STO; Frenette PS; Brockschnieder D; Costa FF; Stasch JP; Sandner P; Conran N
J Pharmacol Exp Ther; 2020 Sep; 374(3):469-478. PubMed ID: 32631869
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase.
Schmidt P; Schramm M; Schröder H; Stasch JP
Eur J Pharmacol; 2003 May; 468(3):167-74. PubMed ID: 12754054
[TBL] [Abstract][Full Text] [Related]
33. Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase.
Martin F; Baskaran P; Ma X; Dunten PW; Schaefer M; Stasch JP; Beuve A; van den Akker F
J Biol Chem; 2010 Jul; 285(29):22651-7. PubMed ID: 20463019
[TBL] [Abstract][Full Text] [Related]
34. The sGC activator BAY 60-2770 has potent erectile activity in the rat.
Lasker GF; Pankey EA; Frink TJ; Zeitzer JR; Walter KA; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1670-9. PubMed ID: 23585129
[TBL] [Abstract][Full Text] [Related]
35. Capillary hemodynamics and contracting skeletal muscle oxygen pressures in male rats with heart failure: Impact of soluble guanylyl cyclase activator.
Weber RE; Schulze KM; Colburn TD; Horn AG; Hageman KS; Ade CJ; Hall SE; Sandner P; Musch TI; Poole DC
Nitric Oxide; 2022 Feb; 119():1-8. PubMed ID: 34871799
[TBL] [Abstract][Full Text] [Related]
36. Higher susceptibility to heme oxidation and lower protein stability of the rare α
Sharina I; Lezgyieva K; Krutsenko Y; Martin E
Biochem Pharmacol; 2021 Apr; 186():114459. PubMed ID: 33571505
[TBL] [Abstract][Full Text] [Related]
37. BAY 41-2272 activates two isoforms of nitric oxide-sensitive guanylyl cyclase.
Koglin M; Stasch JP; Behrends S
Biochem Biophys Res Commun; 2002 Apr; 292(4):1057-62. PubMed ID: 11944922
[TBL] [Abstract][Full Text] [Related]
38. Dental Pulp Inflammation Initiates the Occurrence of Mast Cells Expressing the α
Korkmaz Y; Plomann M; Puladi B; Demirbas A; Bloch W; Deschner J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674416
[TBL] [Abstract][Full Text] [Related]
39. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.
Stasch JP; Schmidt P; Alonso-Alija C; Apeler H; Dembowsky K; Haerter M; Heil M; Minuth T; Perzborn E; Pleiss U; Schramm M; Schroeder W; Schröder H; Stahl E; Steinke W; Wunder F
Br J Pharmacol; 2002 Jul; 136(5):773-83. PubMed ID: 12086987
[TBL] [Abstract][Full Text] [Related]
40. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.
Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT
Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
